BXRX Baudax Bio, Inc.

Baudax Bio, Inc. is a pharmaceutical company focusing on developing and commercializing products for acute care settings. The company was founded in 2015 and is headquartered in Malvern, PA.

$0.15  +0.01 (4.45%)
As of 11/30/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/22/2019
Outstanding shares:  20,003,745
Average volume:  1,134,733
Market cap:   $2,786,522
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -0.22
PB ratio:   0.10
PS ratio:   3.39
Return on equity:   -160.79%
Net income %:   -1,905.84%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy